Henan STEMI Registry
Henan ST-segment Elevation Myocardial Infarction (STEMI) Registry
Henan ST-segment Elevation Myocardial Infarction (STEMI) Registry
Sponsor study identifier
observational
5,479
1 country
1
Study Start
September 2016
Actual (reported)Primary Completion
August 2018
Actual (reported)Study Completion
September 2019
Actual (reported)ST-segment elevation myocardial infarction (STEMI) remains among the most acute and critical diseases, with primary percutaneous coronary intervention (pPCI) and thrombolysis as mainstay reperfusion treatments. Real-world implementation of current guidelines for STEMI management has been assessed in developed countries and large Chinese cities. However, until now, there has been no registry on patients with STEMI in Henan, the most populated (about 100 million) and predominantly rural (66%) province in central China. This registry is aimed to assess management practices, time delays, outcomes and reasons for not receiving reperfusion therapy in consecutive STEMI patients in reperfusion-capable hospitals, i.e., tertiary and secondary, in Henan province.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2019
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 15, 2015
Actual (reported)December 29, 2015
Actual (reported)September 2016
Actual (reported)August 2018
Actual (reported)September 2019
Actual (reported)All causes mortality
At discharge, an average of 10 days
All causes mortality
30 days
adverse cardiovascular and cerebrovascular events (MACCE, death, congestive heart failure, reinfarction and ischemic stroke)
At discharge, an average of 10 days
All causes mortality
6 months
All causes mortality
1 year
STEMI patients within 30 days of symptom onset
Zhengzhou university People's Hospital
Zhengzhou, Henan, 450000, China
Wang S, Zhang Y, Yang W, Wang X, Zhu Z, Qi D, Zhang J, Zhang J, Gao C. Impact of stress hyperglycemia ratio on incidence of in-hospital cardiogenic shock in patients with ST-elevation myocardial infarction: a prospective, multicenter study. Front Endocrinol (Lausanne). 2025 Dec 12;16:1677084. doi: 10.3389/fendo.2025.1677084. eCollection 2025.
Wang S, Zhang Y, Qi D, Wang X, Zhu Z, Yang W, Li M, Hu D, Gao C. Development and validation of a risk score for predicting 30-day mortality in patients with ST elevation myocardial infarction. Sci Rep. 2025 Mar 15;15(1):8930. doi: 10.1038/s41598-025-92615-3.
Chuanyu Gao, MD
Henan Institute of Cardiovascular Epidemiology
Dayi Hu, MD
Henan Institute of Cardiovascular Epidemiology
5,479 participants (actual enrollment reported by the registry).
First Submitted
December 15, 2015
First Posted
December 29, 2015
Study Start
September 2016
Actual (reported)Prognostic Value of Copeptin for Infarct Size and Prognosis in Patients With ST-elevation Myocardial Infarction
Contact the study team to confirm eligibility.
Zhang Y, Wang S, Cheng Q, Zhang J, Qi D, Wang X, Zhu Z, Li M, Hu D, Gao C; Henan STEMI registry Study Group. Reperfusion strategy and in-hospital outcomes for ST elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central China: a multicentre, prospective and observational study. BMJ Open. 2021 Dec 20;11(12):e053510. doi: 10.1136/bmjopen-2021-053510.
Zhang Y, Wang S, Yang S, Yin S, Cheng Q, Li M, Qi D, Wang X, Zhu Z, Zhao L, Hu D, Gao C. Rationale and design of the Henan ST elevation myocardial infarction (STEMI) registry: a regional STEMI project in predominantly rural central China. BMC Cardiovasc Disord. 2019 Nov 28;19(1):271. doi: 10.1186/s12872-019-1250-9.
Primary Completion
August 2018
Actual (reported)Study Completion
September 2019
Actual (reported)Last Updated
August 5, 2022
Record last verified: 2022-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: